Next Article in Journal
Modifying Membranotropic Action of Antimicrobial Peptide Gramicidin S by Star-like Polyacrylamide and Lipid Composition of Nanocontainers
Next Article in Special Issue
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors
Previous Article in Journal
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells
Previous Article in Special Issue
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function
 
 
Perspective

Article Versions Notes

Int. J. Mol. Sci. 2024, 25(16), 8698; https://doi.org/10.3390/ijms25168698
Action Date Notes Link
article xml file uploaded 9 August 2024 10:00 CEST Original file -
article xml uploaded. 9 August 2024 10:00 CEST Update -
article pdf uploaded. 9 August 2024 10:00 CEST Version of Record -
article html file updated 9 August 2024 10:03 CEST Original file -
article xml file uploaded 9 August 2024 11:23 CEST Update -
article xml uploaded. 9 August 2024 11:23 CEST Update https://www.mdpi.com/1422-0067/25/16/8698/xml
article pdf uploaded. 9 August 2024 11:23 CEST Updated version of record https://www.mdpi.com/1422-0067/25/16/8698/pdf
article html file updated 9 August 2024 11:25 CEST Update https://www.mdpi.com/1422-0067/25/16/8698/html
Back to TopTop